No Data
No Data
Mizhuo's Top Picks in Healthcare for July
Morgan Stanley Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $115
Morgan Stanley analyst Vikram Purohit maintains $Axsome Therapeutics(AXSM.US)$ with a buy rating, and maintains the target price at $115.According to TipRanks data, the analyst has a success rate of 2
ResMed, Philips Under Pressure as Eli Lilly Seeks Sleep Indication for Weight Loss Drug
Investors Ignore Increasing Losses at Axsome Therapeutics (NASDAQ:AXSM) as Stock Jumps 7.0% This Past Week
Citi's North America Focus List Updated, Adds: Coca-Cola, Evergy, Etc.
A Quick Look at Today's Ratings for Axsome Therapeutics(AXSM.US), With a Forecast Between $106 to $125
On Jun 12, major Wall Street analysts update their ratings for $Axsome Therapeutics(AXSM.US)$, with price targets ranging from $106 to $125.Morgan Stanley analyst Vikram Purohit maintains with a buy r